Cargando…
Application Analysis of (124)I-PPMN for Enhanced Retention in Tumors of Prostate Cancer Xenograft Mice
BACKGROUND: In recent years, nuclear medicine imaging and therapy for prostate cancer have radically changed through the introduction of radiolabeled prostate-specific membrane antigen (PSMA)-binding peptides. However, these small molecular probes have some inherent limitations, including high nephr...
Autores principales: | Xia, Lei, Wen, Li, Meng, Xiangxi, Zhou, Nina, Guo, Xiaoyi, Liu, Teli, Xu, Xiaoxia, Wang, Feng, Zhu, Hua, Yang, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612089/ https://www.ncbi.nlm.nih.gov/pubmed/34848955 http://dx.doi.org/10.2147/IJN.S330237 |
Ejemplares similares
-
An Albumin-Binding PSMA Ligand with Higher Tumor Accumulation for PET Imaging of Prostate Cancer
por: Ren, Ya’nan, et al.
Publicado: (2022) -
Multimodal Imaging Technology Effectively Monitors HER2 Expression in Tumors Using Trastuzumab-Coupled Organic Nanoparticles in Patient-Derived Xenograft Mice Models
por: Wen, Li, et al.
Publicado: (2021) -
Testosterone inhibits the growth of prostate cancer xenografts in nude mice
por: Song, Weitao, et al.
Publicado: (2017) -
Synthesis and evaluation of (64)Cu-radiolabeled NOTA-cetuximab ((64)Cu-NOTA-C225) for immuno-PET imaging of EGFR expression
por: Xu, Xiaoxia, et al.
Publicado: (2019) -
Volume Retention, Metabolism, and Cellular Composition of Human Fat Xenografts
por: Merrifield, Brittany A., et al.
Publicado: (2018)